Company news
Ovid Therapeutics Inc. news in 2026
Ovid Therapeutics Inc.'s news releases, calls and decks from 2026, newest first.
Ovid Therapeutics to Participate in Upcoming Investor Conferences
November 5, 2026
Ovid Therapeutics to Participate in Upcoming Investor Conferences
September 3, 2026
Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
August 13, 2026
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
July 8, 2026
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
June 3, 2026
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
May 12, 2026
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14
April 7, 2026
Ovid Therapeutics Announces Pricing of $60 Million Private Placement
March 17, 2026
Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results
March 17, 2026
Ovid Therapeutics to Participate in Upcoming Investor Conferences
February 24, 2026
Calls in 2026
Decks in 2026
- Q4 2025 Earnings Presentation
Earnings · 41 slides · Mar 18, 2026